AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis

Affiliations

¹ Section of Hepatology, Virginia Commonwealth University, Richmond, Virginia, USA.
² Division of Gastroenterology and Hepatology, Northwestern Medicine and Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
³ Division of Gastroenterology and Hepatology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
⁴ Baylor University Medical Center, Dallas, Texas, USA.
⁵ Mayo Clinic Evidence-Based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.
⁶ Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA.
⁷ VA Connecticut Healthcare System, West Haven, Connecticut, USA.
⁸ Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
⁹ Department of Pediatrics, Baylor College of Medicine and Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Hospital, Houston, Texas, USA.
¹⁰ Department of Radiology, Beth Israel Lahey Health, Harvard Medical School, Boston, Massachusetts, USA.
¹¹ Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
¹² Digestive Disease Research Center, Medical University of South Carolina, Charleston, South Carolina, USA.

Richard K Sterling et al. Hepatology. 2025.

. 2025 Feb 1;81(2):672-724.

doi: 10.1097/HEP.0000000000000843. Epub 2024 Mar 15.

¹ Section of Hepatology, Virginia Commonwealth University, Richmond, Virginia, USA.
² Division of Gastroenterology and Hepatology, Northwestern Medicine and Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
³ Division of Gastroenterology and Hepatology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
⁴ Baylor University Medical Center, Dallas, Texas, USA.
⁵ Mayo Clinic Evidence-Based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.
⁶ Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA.
⁷ VA Connecticut Healthcare System, West Haven, Connecticut, USA.
⁸ Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
⁹ Department of Pediatrics, Baylor College of Medicine and Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Hospital, Houston, Texas, USA.
¹⁰ Department of Radiology, Beth Israel Lahey Health, Harvard Medical School, Boston, Massachusetts, USA.
¹¹ Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
¹² Digestive Disease Research Center, Medical University of South Carolina, Charleston, South Carolina, USA.

No abstract available

Comment in

Getting persuasive about the non-invasive: assessing liver fibrosis in practice-without a biopsy.
Ansari N, Twohig P. Ansari N, et al. Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):879-881. doi: 10.21037/hbsn-24-445. Epub 2024 Sep 26. Hepatobiliary Surg Nutr. 2024. PMID: 39507720 Free PMC article. No abstract available.

1. Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650–2666.
1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151–171.
1. Bravo AA, Sheth SG, Chopra S. Liver biopsy. New Engl J Med. 2001;344:495–500.
1. Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Digest Dis Sci. 1993;38:1480–1484.
1. Sterling RK, Asrani SK, Levine D, et al. AASLD Practice Guideline: Noninvasive Liver Disease Assessments of Portal Hypertension. Hepatology. 2024. doi:10.1097/HEP.0000000000000844. - DOI